XB-ART-59594
Biomolecules
2023 Feb 06;132:. doi: 10.3390/biom13020301.
Show Gene links
Show Anatomy links
Do Amino Acid Antiporters Have Asymmetric Substrate Specificity?
Gauthier-Coles G
,
Fairweather SJ
,
Bröer A
,
Bröer S
.
???displayArticle.abstract???
Amino acid antiporters mediate the 1:1 exchange of groups of amino acids. Whether substrate specificity can be different for the inward and outward facing conformation has not been investigated systematically, although examples of asymmetric transport have been reported. Here we used LC-MS to detect the movement of 12C- and 13C-labelled amino acid mixtures across the plasma membrane of Xenopus laevis oocytes expressing a variety of amino acid antiporters. Differences of substrate specificity between transporter paralogs were readily observed using this method. Our results suggest that antiporters are largely symmetric, equalizing the pools of their substrate amino acids. Exceptions are the antiporters y+LAT1 and y+LAT2 where neutral amino acids are co-transported with Na+ ions, favouring their import. For the antiporters ASCT1 and ASCT2 glycine acted as a selective influx substrate, while proline was a selective influx substrate of ASCT1. These data show that antiporters can display non-canonical modes of transport.
???displayArticle.pubmedLink??? 36830670
???displayArticle.pmcLink??? PMC9953452
???displayArticle.link??? Biomolecules
Species referenced: Xenopus laevis
Genes referenced: pycard slc1a4
GO keywords: glutamine transport [+]
???attribute.lit??? ???displayArticles.show???
|
|
|
|
|
|
|
|
|
Figure 1. Simulation of symmetric and asymmetric antiporter kinetics in an artificial cell containing LAT2 only. The concentration of cytosolic and extracellular amino acids was set at 1 mM. (a) Intracellular concentrations of all substrate amino acids when LAT2 intracellular KM values were scaled to be 180-fold higher than extracellular KM values. (b) Intracellular concentrations of all substrate amino acids when the intracellular KM value of Gly was scaled to be 0.6-fold higher than the extracellular KM value (all other KM values as in (a)). Gly (beige) is leaving the cell in exchange for all other substrates of the transporter. |
|
Figure 2. Analysis of Xenopus laevis oocyte amino acid pools. (a) After expression for five days oocytes were incubated with 12C (black) and 13C amino acids (red) in the order shown. Three samples were analysed for each experiment, namely the preload sample, supernatant sample and extract sample. (b) Cytosolic amino acid concentrations after incubation in a 1 mM 12C amino acid mix of oocytes expressing 4F2hc, 4F2hc + LAT1 or 4F2hc + LAT2 (Preload sample). Isoleucine and leucine cannot be separated by LC–MS and their sum is shown as IL. |
|
Figure 3. Analysis of antiport via LAT1 and LAT2. Oocytes expressing 4F2hc–LAT1 (a) or 4F2hc–LAT2 (b) were incubated with labelled and unlabelled amino acids as described in Figure 2a. Net import (positive numbers) and net export (negative numbers) are shown. Isoleucine and leucine cannot be separated by LC–MS and are shown as IL. The activity of oocytes expressing 4F2hc alone was subtracted, resulting in apparent oppositely-directed transport for some amino acids. |
|
Figure 4. Analysis of asymmetry and uniport activity of LAT1 and LAT2. (a) Uptake of 0.1 mM [14C]glutamine was measured in the presence and absence of an unlabelled amino acid mix (0.1 mM each) in oocytes expressing 4F2hc, 4F2hc–LAT2 or non-injected oocytes. (b) Oocytes expressing 4F2hc, 4F2hc–LAT2 or non-injected oocytes were preincubated with 0.1 mM [14C]glutamine for 1h. After washing, oocytes were incubated in ND96 in the presence (+Q) and absence (−Q) of 1 mM glutamine and supernatant samples were analysed for radiolabelled glutamine after 15 and 30 min. (c) Oocytes expressing 4F2hc, 4F2hc–LAT1 or 4F2hc–LAT2 were incubated in ND96 for 2 h after which the supernatant was analysed for amino acids to calculate net efflux. Isoleucine and leucine cannot be separated by LC–MS and are shown as IL. *** Significant difference at p < 0.0001. |
|
Figure 5. Analysis of antiport via y+LAT1 and y+LAT2. Oocytes expressing 4F2hc–y+LAT1 (a) or 4F2hc–y+LAT2 (b) were incubated with labelled and unlabelled amino acids as described in Figure 2a. Net import (positive numbers) and net export (negative numbers) are shown. Isoleucine and leucine cannot be separated by LC–MS and are shown as IL. |
|
Figure 6. Analysis of antiport via asc-1 and xCT. Oocytes expressing 4F2hc–asc-1 (a) or 4F2hc–xCT (b) were incubated with labelled and unlabelled amino acids as described in Figure 2a. Net import (positive numbers) and net export (negative numbers) are shown. Isoleucine and leucine cannot be separated by LC–MS and are shown as IL. |
|
Figure 7. Analysis of antiport via ASCT1 and ASCT2. Oocytes expressing ASCT1 (a) or ASCT2 (b) were incubated with labelled and unlabelled amino acids as described in Figure 1a. Net import (positive numbers) and net export (negative numbers) are shown. Isoleucine and leucine cannot be separated by LC–MS and are shown as IL. |
|
Figure 8. Analysis of ASCT1-mediated proline and aspartate transport. (a) Uptake of 0.1 mM [14C]proline was measured after 30 min in the presence and absence of an unlabelled amino acid mix (0.1 mM each) in oocytes expressing ASCT1 or in non-injected oocytes. (b) Oocytes expressing ASCT1 or non-injected oocytes were preincubated with 0.1 mM [14C]proline for 1h. After washing, oocytes were incubated in ND96 in the presence (+Thr) and absence (−Thr) of 1 mM threonine and supernatant samples were analysed for radiolabelled proline after 15 and 30 min. Due to the difference in preloading, efflux is shown as % of preloaded [14C]proline. (c) Uptake of 0.025 mM [14C]aspartate was measured after 25 min in oocytes expressing ASCT1 or in non-injected oocytes. (d) Oocytes expressing ASCT1 were preincubated with 0.025 mM [14C]aspartate for 2h. After washing, oocytes were incubated in ND96 in the presence (+Ala) and absence (ND96) of 1 mM alanine and supernatant samples were analysed for radiolabelled aspartate after 15 and 30 min. Due to the difference in preloading, efflux is shown as % of preloaded [14C]aspartate. |
References [+] :
Alleva,
Molecular Basis of Coupled Transport and Anion Conduction in Excitatory Amino Acid Transporters.
2022, Pubmed
Alleva, Molecular Basis of Coupled Transport and Anion Conduction in Excitatory Amino Acid Transporters. 2022, Pubmed
Bannai, Transport of cystine and cysteine in mammalian cells. 1984, Pubmed
Boudker, Structural perspectives on secondary active transporters. 2010, Pubmed
Bröer, Amino Acid Homeostasis in Mammalian Cells with a Focus on Amino Acid Transport. 2022, Pubmed
Bröer, Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. 2016, Pubmed
Bröer, Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains. 2001, Pubmed , Xenbase
Bröer, The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine. 2000, Pubmed , Xenbase
Bröer, Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 (MCT 1) expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons. 1997, Pubmed , Xenbase
Bröer, Discrimination of two amino acid transport activities in 4F2 heavy chain- expressing Xenopus laevis oocytes. 1998, Pubmed , Xenbase
Bröer, Xenopus laevis Oocytes. 2010, Pubmed , Xenbase
Bröer, Amino acid transporters as modulators of glucose homeostasis. 2022, Pubmed
Bröer, Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance. 2000, Pubmed , Xenbase
Bröer, Regulation of the glutamine transporter SN1 by extracellular pH and intracellular sodium ions. 2002, Pubmed , Xenbase
Bröer, The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux. 1999, Pubmed , Xenbase
Chillarón, Heteromeric amino acid transporters: biochemistry, genetics, and physiology. 2001, Pubmed
Cloherty, Regulation of GLUT1-mediated sugar transport by an antiport/uniport switch mechanism. 1996, Pubmed
Coady, rBAT is an amino acid exchanger with variable stoichiometry. 1996, Pubmed , Xenbase
Das, Impact of Inhibition of Glutamine and Alanine Transport on Cerebellar Glial and Neuronal Metabolism. 2022, Pubmed
Devés, Transporters for cationic amino acids in animal cells: discovery, structure, and function. 1998, Pubmed , Xenbase
Erecińska, Cerebral aspartate utilization: near-equilibrium relationships in aspartate aminotransferase reaction. 1993, Pubmed
Errasti-Murugarren, L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction. 2019, Pubmed
Fairweather, Coordinated action of multiple transporters in the acquisition of essential cationic amino acids by the intracellular parasite Toxoplasma gondii. 2021, Pubmed , Xenbase
Fairweather, A GC-MS/Single-Cell Method to Evaluate Membrane Transporter Substrate Specificity and Signaling. 2021, Pubmed , Xenbase
Forrest, The structural basis of secondary active transport mechanisms. 2011, Pubmed
Fotiadis, The SLC3 and SLC7 families of amino acid transporters. 2013, Pubmed
Fukasawa, Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. 2000, Pubmed , Xenbase
Garaeva, A one-gate elevator mechanism for the human neutral amino acid transporter ASCT2. 2019, Pubmed
Garaeva, Cryo-EM structure of the human neutral amino acid transporter ASCT2. 2018, Pubmed
Gauthier-Coles, Quantitative modelling of amino acid transport and homeostasis in mammalian cells. 2021, Pubmed
Grewer, New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak. 2004, Pubmed
Guan, A simultaneous liquid chromatography/mass spectrometric assay of glutathione, cysteine, homocysteine and their disulfides in biological samples. 2003, Pubmed
Kanai, Transport properties of a system y+L neutral and basic amino acid transporter. Insights into the mechanisms of substrate recognition. 2000, Pubmed , Xenbase
Kanai, The SLC1 high-affinity glutamate and neutral amino acid transporter family. 2013, Pubmed
Kekuda, Molecular and functional characterization of intestinal Na(+)-dependent neutral amino acid transporter B0. 1997, Pubmed , Xenbase
Le Guellec, Flux coupling, not specificity, shapes the transport and phylogeny of SLC6 glycine transporters. 2022, Pubmed , Xenbase
Levy, Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. 1998, Pubmed
Mazza, The involvement of sodium in the function of the human amino acid transporter ASCT2. 2021, Pubmed
Meier, Activation of system L heterodimeric amino acid exchangers by intracellular substrates. 2002, Pubmed , Xenbase
Mizraji, The biological Maxwell's demons: exploring ideas about the information processing in biological systems. 2021, Pubmed
Nath, The new unified theory of ATP synthesis/hydrolysis and muscle contraction, its manifold fundamental consequences and mechanistic implications and its applications in health and disease. 2008, Pubmed
Nicolàs-Aragó, Rush Hour of LATs towards Their Transport Cycle. 2021, Pubmed
Palacín, A new family of proteins (rBAT and 4F2hc) involved in cationic and zwitterionic amino acid transport: a tale of two proteins in search of a transport function. 1994, Pubmed , Xenbase
Pfeiffer, Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. 1999, Pubmed , Xenbase
Pineda, Cystinuria-specific rBAT(R365W) mutation reveals two translocation pathways in the amino acid transporter rBAT-b0,+AT. 2004, Pubmed , Xenbase
Pingitore, Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris--functional and kinetic asymmetry revealed in proteoliposomes. 2013, Pubmed
Pino, The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics. 2020, Pubmed
Sato, Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. 1999, Pubmed , Xenbase
Scalise, ASCT1 and ASCT2: Brother and Sister? 2021, Pubmed
Scalise, Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter. 2015, Pubmed
Scalise, Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5). 2014, Pubmed
Scalise, The Human SLC1A5 Neutral Amino Acid Transporter Catalyzes a pH-Dependent Glutamate/Glutamine Antiport, as Well. 2020, Pubmed
Scopelliti, Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members. 2013, Pubmed , Xenbase
Segawa, Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. 1999, Pubmed , Xenbase
Shi, The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site. 2008, Pubmed
Stegen, Swelling-induced taurine release without chloride channel activity in Xenopus laevis oocytes expressing anion channels and transporters. 2000, Pubmed , Xenbase
Sutton, A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome. 2018, Pubmed
Taylor, Accumulation of free amino acids in growing Xenopus laevis oocytes. 1987, Pubmed , Xenbase
Torrents, Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance. 1998, Pubmed , Xenbase
Van Winkle, Importance of direct determination of amino acid co- and counter-transport stoichiometries. 2001, Pubmed
Wagner, Function and structure of heterodimeric amino acid transporters. 2001, Pubmed
Wagner, The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins. 2000, Pubmed , Xenbase
Wang, Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2. 2022, Pubmed
Widdows, Integration of computational modeling with membrane transport studies reveals new insights into amino acid exchange transport mechanisms. 2015, Pubmed
Yanagida, Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. 2001, Pubmed , Xenbase
Zander, Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2. 2013, Pubmed